News Sentiment

XTLB sentiment intelligence

XTL Biopharmaceuticals Ltd ADR news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 46 Balanced news tone 44 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 2.91 Week of 10 Jul 2026
Weighted tone 46/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

78/100 classification confidence.

Company focus 36

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend inactive

+7.8% over one week, +36.6% over four weeks, trend inactive, and below fair value.

Latest direct headline Neutral

Enterprise value to EBITDA forward of XTL Biopharmaceuticals Ltd. Sponsored ADR – LSX:A41X7J

Market Reaction

Price moving ahead of tone

62/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 78/100 classification
One-week reaction 7.8% Price confirming higher
Trend fit Trend inactive 36.6% over four weeks
Fair value -47.3% Below fair value
Market Dynamics buy signal Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 6
Neutral 27
Negative 11

Relevance

Why the article matched

Direct first
Direct company coverage 36
Industry context 8
Sector context 0

Sources

Coverage mix

Publishers
TradingKey 7
Market source 6
TradingView 6
Stock Titan 6
Moomoo 3
Quiver Quantitative 3
The Manila Times 2
simplywall.st 2

Event Lens

What the news is about

Classified themes
Market update 21
Earnings 14
Deals and strategy 8
Guidance 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-44 of 44
Intellectia AI Direct company coverage

XTLB Technical Analysis & Stock Price Forecast

This article provides a technical analysis and stock price forecast for X T L Biopharmaceuticals Ltd (XTLB), indicating a "Sell" consensus based on various technical indicators and moving averages. While some oscillators show "Buy" signals, the overall sentiment is bearish, with

Tone
Negative 31/100
Event
Guidance
Published
16 May 2026 01:09
Source
Intellectia AI